Table 1.
Characterization of AT-MSCs and BM-MSCs by surface marker expression with flow cytometry analysis. Clone information for marker antibodies is also provided.
| Marker | Clone | % Expression in Cells (Average ± Standard Deviation) |
|
|---|---|---|---|
| AT-MSC (n = 5) | BM-MSC (n = 4) | ||
| CD14 | M5E2 | 1.7 ± 2.8 | 0.4 ± 0.3 |
| CD19 | HIB19 | 0.3 ± 0.4 | 0.3 ± 0.2 |
| CD34 | 581 | 31.9 ± 25.4 | 1.1 ± 1.4 |
| CD45RO | UCHL1 | 1.4 ± 2.3 | 0.5 ± 0.3 |
| CD54 | HA58 | 61.8 ± 22.8 | 12.4 ± 2.2 |
| CD73 | AD2 | 99.0 ± 1.8 | 99.5 ± 0.3 |
| CD90 | 5E10 | 99.3 ± 0.7 | 94.6 ± 5.1 |
| CD105 | 266 | 96.1 ± 7.1 | 98.2 ± 1.0 |
| HLA-DR | G46-6 | 1.7 ± 3.1 | 1.5 ± 0.8 |